Reni Benjamin
Stock Analyst at Citizens Capital Markets
(0)
# 4580
Out of 5,319 analysts
232
Total ratings
26.03%
Success rate
-20.56%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CUE Cue Biopharma | Reiterates: Market Outperform | 2 2 | 0.76 | 163.16% | 5 | Apr 2, 2025 | |
BCAB BioAtla | Maintains: Market Outperform | 5 1 | 0.32 | 212.5% | 9 | Mar 31, 2025 | |
SANA Sana Biotechnology | Upgrades: Market Outperform | 5 | 1.65 | 203.03% | 5 | Mar 18, 2025 | |
INBX Inhibrx Biosciences | Reiterates: Market Perform | n/a | n/a | n/a | 9 | Mar 18, 2025 | |
STRO Sutro Biopharma | Downgrades: Market Perform | n/a | n/a | n/a | 10 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Outperform | 5 | 1.45 | 244.83% | 7 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 7 8 | 4.48 | 78.57% | 1 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 4 4 | 0.81 | 393.83% | 4 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 28 | Mar 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 5 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 60 60 | 54.79 | 9.51% | 1 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 125 125 | 84.69 | 47.6% | 21 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 26 26 | 7.39 | 251.83% | 13 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 32 32 | 24.61 | 30.03% | 2 | Feb 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 315 315 | 221.02 | 42.52% | 1 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 265 265 | 222.23 | 19.25% | 1 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 28 28 | 5.9 | 374.58% | 9 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 12 4 | 0.92 | 334.78% | 5 | Jan 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 6 6 | 1.31 | 358.02% | 6 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 288 | n/a | n/a | 1 | Sep 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 25 23 | 3.06 | 651.63% | 10 | Jun 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 6 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 4 | Jan 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | n/a | n/a | n/a | 7 | May 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 4 | Apr 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 6 | Mar 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 50 25 | n/a | n/a | 5 | Jan 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 8 4 | 1.47 | 172.11% | 1 | Aug 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Aug 24, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Mar 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | n/a | n/a | n/a | 4 | Nov 12, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Outperform | 28 17 | 3.16 | 437.97% | 3 | Nov 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 36 | n/a | n/a | 1 | Jun 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 17 | n/a | n/a | 3 | Mar 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Dec 3, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Nov 15, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | n/a | n/a | n/a | 4 | Jun 14, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 3 | Jun 14, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | n/a | n/a | n/a | 2 | Feb 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Strong Buy | 72 | n/a | n/a | 2 | Nov 7, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 16 | 0.24 | 6566.67% | 1 | Oct 22, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 11 10 | 21.31 | -53.07% | 2 | Oct 12, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Outperform | 22 12 | 38.32 | -68.68% | 1 | Sep 25, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Nov 15, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 1200 0 | n/a | n/a | 2 | Nov 10, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 3 | Aug 29, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Outperform | n/a | n/a | n/a | 2 | May 5, 2017 |